And yet there is the total absurdity of cannabis federally
And yet there is the total absurdity of cannabis federally classified, for the past 43 years, as a Schedule 1 drug, which classification is reserved for the most dangerous drugs or substances deemed by D E A to be unsafe, of no medical value, and highly restricted even for clinical studies. Not mentioning the thousands of people sitting in prisons at enormous taxpayer expense because of Schedule 1 classification for mj.
Schedule I drugs are those that have the following characteristic according to the United States Drug Enforcement Agency:
The drug or other substance has a high potential for abuse.
The drug or other substance has no currently accepted medical treatment use in the U.S.
There is a lack of accepted safety for use of the drug or substance under medical supervision.
No prescriptions may be written for Schedule I substances, and they are not readily available for clinical use.
SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of LATAM SSP Market Share Rankings London — Pixalate, a global frontrunner in ad fraud analytics and privacy compliance, has published its Q1 2025 Supply-Side Platform (SSP) market share reports for Latin America (LATAM). This comprehensive analysis covers significant landscapes such as Connected TV (CTV), mobile applications, and the web, spotlighting...
Continue Reading
Singtel's Innovative RE:AI Project Takes Center Stage By seamlessly integrating compute, connectivity, and applications orchestration, Singtel's RE:AI is transforming the AI infrastructure landscape and setting fresh benchmarks in GPU-as-a-Service delivery. This project, spearheaded by its digital infrastructure sector known as Digital InfraCo, signifies an important...
Continue Reading
Shareholder Investigations: An Overview In recent months, Grabar Law Office has taken significant steps to investigate potential breaches of fiduciary duties affecting shareholders of several prominent companies. Shareholders deserve to know if their interests have been compromised by those in positions of authority, and as such, active investigations have commenced....
Continue Reading
Synaptics to Showcase Innovations at Investor Conferences SAN JOSE, Calif. — Synaptics Incorporated (NASDAQ: SYNA) has announced an exciting opportunity for investors, as the company is set to participate in significant upcoming investor conferences. These events aim to highlight Synaptics' commitment to innovation, particularly its pioneering work in artificial...
Continue Reading
Kite Realty Group Reports Strong Financial Performance in Q2 2025 Kite Realty Group (NYSE: KRG), a leader in managing grocery-anchored retail centers, announced impressive operating results for the second quarter of 2025. The company reported a net income attributable to common shareholders of $110.3 million, or $0.50 per diluted share, a significant turnaround from the...
Continue Reading
